Recherche
-
Persistent cortisol response to desmopressin predicts recurrence of Cushing's disease in patients with post-operative corticotropic insufficiency
(European Journal of Endocrinology. vol. 182, n° 5, pp. 489-498, 2020-05)Article de revue -
Expression of Functional Cannabinoid Type-1 (CB1) Receptor in Mitochondria of White Adipocytes
(Cells. vol. 11, n° 16, pp. 2582, 2022-08-19)Article de revueLibre accès -
NOS1 mutations cause hypogonadotropic hypogonadism with sensory and cognitive deficits that can be reversed in infantile mice
(Science Translational Medicine. vol. 14, n° 665, 2022-10-05)Article de revueLibre accès -
Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing–Remitting Multiple Sclerosis After Fingolimod Withdrawal
(Neurotherapeutics. vol. 19, n° 2, pp. 476-490, 2022-03)Article de revueLibre accès -
Switch of serotonergic descending inhibition into facilitation by a spinal chloride imbalance in neuropathic pain
(Science Advances. vol. 8, n° 30, 2022-07-29)Article de revueLibre accès -
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis
(JAMA neurology. vol. 81, n° 3, pp. 273-282, 2024-03-01)Article de revueLibre accès -
Yin-Yang control of energy balance by lipids in the hypothalamus: The endocannabinoids vs bile acids case
(Biochimie, 2022)Article de revueLibre accès -
Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates
(Science Advances. vol. 6, n° 20, 2020-05-13)Article de revueLibre accès -
GnRH replacement rescues cognition in Down syndrome
(2022)Document de travail - Pré-publicationLibre accès -
The CB1 cannabinoid receptor regulates autophagy in the tibialis anterior skeletal muscle in mice
(Biological Research. vol. 56, n° 1, pp. 14, 2023-03-25)Article de revueLibre accès